Join us and Dr. Kebbie Josan to discuss heart disease in Asians and effective ways to prevent and treat heart disease in South Asians!

South Asians (people from India, Pakistan, Bangladesh, Nepal, Bhutan, Maldives and Sri Lanka) have a higher risk of heart and vascular disease than any other ethnic groups.

Dr. Kiranbir Josan, MD, is a Clinical Assistant Professor of Cardiovascular Medicine at the Stanford University School of Medicine and a board certified Cardiologist. She enjoys practicing all areas of cardiology with a special interest in primary and secondary prevention, valvular heart disease, cardiomyopathy, atrial fibrillation and other arrhythmia management. Her current clinical and research focus includes taking a comprehensive approach to managing a patient's cardiometabolic health. She is also interested in digital health technologies and how they can be used to improve healthcare delivery and patient outcomes.

Join us and Dr. Joo Ha Hwang to discuss the prevention and treatment of gastrointestinal disease in Asian populations!

Gastric cancer is the third leading cause of cancer death worldwide and is diagnosed in 27,000 Americans each year. In the United States, this burden falls disproportionately on ethnic minorities and immigrant communities, especially Asians. There exists no coherent national strategy for the early detection or risk attenuation of gastric cancer, even among identified high-risk groups. The under-recognition of gastric cancer risk among minority communities may be one of the most significant unaddressed healthcare disparities in the United States. There is a need for a national dialogue on strategies to decrease morbidity and mortality from gastric cancer in the United States, especially among the most vulnerable populations.

Stay tuned for more information, coming soon!

Dr. Eric Gross is an anesthesiologist developing non-narcotic cardiac-safe pain therapeutics. The Gross Lab is designing next generation analgesics that are safe to use for those with cardiovascular disease. Dr. Gross's previous basic science research background involves examining the mechanism of how opioids and volatile anesthetics protect tissue from ischemia-reperfusion injury and what are the molecular mechanisms involved both through in vivo and cellular models of ischemia-reperfusion injury. 

Dr. Che-Hong Chen is a molecular biologist and geneticist at the Stanford University School of Medicine. Dr. Chen’s research is highlighted by the discovery of a class of novel enzyme modulators of aldehyde dehydrogenase. Some of these small molecule modulators are potent enzyme activators for the variant East Asian-specific dysfunctional ALDH2, which causes the alcohol flushing syndrome. Dr. Chen is now actively promoting public health education, cancer prevention and the awareness of health risks associated with harmful alcohol use and alcohol flushing caused by ALDH2 deficiency in Taiwan and East Asia.

Join us and Dr. Neeta Gautam to discuss Ayurvedic medicine, the "Science of Life."

Stay tuned for more information, coming soon!